Anticancer peptoid 1
Anticancer peptoid 1 (Peptoid 1) is a peptoid with antitumor activity. Anticancer peptoid 1 exerts cytotoxicity primarily via plasma membrane damage. Anticancer peptoid 1 exerts cytotoxicity against a broad range of cancer cell lines, including those with multidrug resistance. Anticancer peptoid 1 inhibits tumor growth in a human breast cancer xenotransplantation mouse model without noticeable acute adverse effects. Anticancer peptoid 1 can be used for the research of cancer, such as breast cancer, and prostate cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 620948-14-3
- 화학식: C104H139N17O12
- 분자량:1819.32
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HaCaT | ED50 |
20 μM
Compound: 13
|
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability pretreated for 1 hr followed by DMEM addition measured after 24 hrs by alamar blue assay
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability pretreated for 1 hr followed by DMEM addition measured after 24 hrs by alamar blue assay
|
[PMID: 30108804] |
Anticancer peptoid 1 (72 h) potently induces cytotoxicity in MCF-7, LNCaP, OVCAR-3, MRC-5, and primary dermal fibroblast cells with LC50 values of 5, 5, 6, 8, and 8 μM respectively after 72 h treatment[1].
Anticancer peptoid 1 (0-50 μM; 72 h) potently induces cytotoxicity in both MCF-7 and multidrug-resistant MCF-7/TxT50 cells, overcoming multidrug resistance[1].
Anticancer peptoid 1 (50 μM; 5-60 min) induces rapid plasma membrane damage in MCF-7 cells, with 50 μM causing ~50% LDH leakage[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7 (human breast cancer) cells
-
Concentration:50 μM (for 50% LDH leakage measurement)
-
Incubation Time:5, 30, 60 min
-
Result:Caused fast LDH release into media; 50 μM peptoid 1 induced ~50% LDH leakage.
Induced rapid plasma membrane damag.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NOD.Cg-Prkdcscid Il2rgtmlWjl/SzJ (NSG) (4-8 week old female, immunocompromised, orthotopic xenograft model via mammary fat pad injection of human breast cancer cells)[1]
-
Dosage:1 mg/kg
-
Administration:Mammary fat pad injection; three times per week; 12 weeks
-
Result:Significantly inhibited tumor growth compared to the control peptoid, with a p-value of 0.0014.
Showed no noticeable acute adverse effects.
Chemical Information
-
CAS No. 620948-14-3
-
분자량 1819.32
-
화학식 C104H139N17O12
-
Synonyms
Peptoid 1
-
Sequence
({NLys}-{Nspe}-{Nspe})4-NH2
-
Sequence Shortening
({NLys}-{Nspe}-{Nspe})4-NH2
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)